Recent

% | $
Quotes you view appear here for quick access.

Alimera Sciences, Inc. (ALIM) Message Board

  • yoshee_1007 yoshee_1007 Feb 28, 2012 7:24 AM Flag

    Aapproval of ILUVIEN(R) for the Trean

    Alimera Sciences Announces Positive Outcome to the European Decentralized Procedure for Approval of ILUVIEN(R) for the Treatment of Chronic Diabetic Macular Edema
    6:30a ET February 28, 2012 (GlobeNewswire)


    -- ILUVIEN(R) expected to be the first sustained release pharmaceutical in
    the European Union to treat diabetic macular edema (DME)
    -- ILUVIEN expected to be indicated for chronic DME considered
    insufficiently responsive to available therapies

 
ALIM
4.79+0.02(+0.42%)4:00 PMEDT